Moviprep and Skin - clammy - a phase IV clinical study of FDA data

Summary:

Skin - clammy is reported as a side effect among people who take Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lyrica, and have Cerebral infarction.

The phase IV clinical study analyzes which people have Skin - clammy when taking Moviprep. It is created by eHealthMe based on reports of 3,148 people who have side effects when taking Moviprep from the FDA, and is updated regularly.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

What is Skin - clammy?

Skin - clammy is found to be associated with 1,129 drugs and 1,708 conditions by eHealthMe. Check the latest studies of Skin - clammy.

On Jul, 02, 2026

3,148 people reported to have side effects when taking Moviprep.
Among them, 19 people (0.6%) have Skin - clammy.

Among these 19 people:

How long have people been on Moviprep when they have Skin - clammy? *

What is the gender of people who have Skin - clammy when taking Moviprep? *

female: 47.37 %
male: 52.63 %

What is the age of people who have Skin - clammy when taking Moviprep? *

What are other drugs people take besides Moviprep? *

What are other side effects people have besides Skin - clammy? *

Nausea (feeling of having an urge to vomit): 7 people, 36.84%
Feeling Abnormal: 4 people, 21.05%
Nausea And Vomiting: 4 people, 21.05%
Presyncope: 3 people, 15.79%
Hypotension (abnormally low blood pressure): 3 people, 15.79%
Loss Of Consciousness: 3 people, 15.79%
Paleness (unusual lightness of skin colour): 3 people, 15.79%
Fatigue (feeling of tiredness): 2 people, 10.53%
Fainting (loss of consciousness and postural tone): 2 people, 10.53%
Hyperkalemia (damage to or disease of the kidney): 2 people, 10.53%

What are the existing conditions these people have? *

Occult Blood Positive: 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and have Skin - clammy?

- Check whether Skin - clammy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Moviprep:

Moviprep (3,173 reports)

Skin - clammy treatments and more:

Skin - clammy (19,745 reports)

How severe was Skin - clammy and when was it recovered:

Skin - clammy in Moviprep

Expand to all the drugs that have ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate:

Skin - clammy and drugs with ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Moviprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin - clammy:

Skin - clammy (1,129 drugs)

Browse all the conditions that are associated with Skin - clammy:

Skin - clammy (1,708 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate (the active ingredients of Moviprep) and Moviprep (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.